Retractable Technologies (NYSE:RVP) vs. Hyperfine (NASDAQ:HYPR) Head to Head Contrast

Retractable Technologies (NYSE:RVP) and Hyperfine (NASDAQ:HYPR) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations.

Institutional & Insider Ownership

7.6% of Retractable Technologies shares are owned by institutional investors. Comparatively, 15.0% of Hyperfine shares are owned by institutional investors. 59.5% of Retractable Technologies shares are owned by company insiders. Comparatively, 26.3% of Hyperfine shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Profitability

This table compares Retractable Technologies and Hyperfine’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Retractable Technologies	-41.11%	-17.15%	-9.33%
Hyperfine	-210.75%	-97.88%	-61.81%

Valuation and Earnings

This table compares Retractable Technologies and Hyperfine”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Retractable Technologies	$33.90 million	0.64	-$7.01 million	($0.12)	-6.00
Hyperfine	$11.40 million	8.39	-$35.57 million	($0.38)	-2.37

Retractable Technologies has higher revenue and earnings than Hyperfine. Retractable Technologies is trading at a lower price-to-earnings ratio than Hyperfine, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Retractable Technologies has a beta of 1.22, meaning that its stock price is 22% more volatile than the S&P 500. Comparatively, Hyperfine has a beta of 1.42, meaning that its stock price is 42% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Retractable Technologies and Hyperfine, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Retractable Technologies	0	0	0	0	0.00
Hyperfine	1	1	3	0	2.40

Hyperfine has a consensus price target of $2.03, suggesting a potential upside of 125.47%. Given Hyperfine’s stronger consensus rating and higher probable upside, analysts clearly believe Hyperfine is more favorable than Retractable Technologies.

Summary

Retractable Technologies beats Hyperfine on 8 of the 14 factors compared between the two stocks.

About Retractable Technologies

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.

About Hyperfine

Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.